1 INTRODUCTION OF GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY TECHNOLOGY
5.1 OVERVIEW
5.2 PCR-BASED AMPLIFICATION
5.3 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION
5.4 NUCLEIC ACID SEQUENCE BASED AMPLIFICATION
5.5 STRAND DISPLACEMENT AMPLIFICATION
5.6 MULTIPLE DISPLACEMENT AMPLIFICATION
5.7 ROLLING CIRCLE AMPLIFICATION
5.8 RAMIFICATION AMPLIFICATION
5.9 OTHERS
6 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY DOWNSTREAM
6.1 OVERVIEW
6.2 WHOLE GENOME AMPLIFICATION
6.3 EXOME SEQUENCING
6.4 SNP GENOTYPING ARRAYS
6.5 ARRAY CGH
6.6 HYBRIDIZATION
6.7 OTHERS
7 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY SAMPLE TYPE
7.1 OVERVIEW
7.2 SINGLE CELL
7.3 FFPE
7.4 OTHERS

8 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INSTRUMENTS
8.3 KITS & REAGENTS
8.4 SERVICES

9 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY END-USE
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 OTHERS

10 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY GEOGRAPHY
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO
10.3 EUROPE
10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3. 1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE

10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA
11 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES
12 COMPANY PROFILES
12.1 4BASEBIO AG
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS
12.2 BIO-RAD LABORATORIES
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS
12.3 DANAHER CORPORATION
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS
12.4 ILLUMINA INC.
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS
12.5 LGC GROUP
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS
12.6 MERCK KGAA
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS
12.7 MYBIOSOURCE
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS
12.8. NEW ENGLAND BIOLABS
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS
12.9 PROMEGA CORPORATION
12.9.1 OVERVIEW
12.9.2 FINANCIAL PERFORMANCE
12.9.3 PRODUCT OUTLOOK
12.9.4 KEY DEVELOPMENTS
12.10 QIAGEN
12.10.1 OVERVIEW
12.10.2 FINANCIAL PERFORMANCE
12.10.3 PRODUCT OUTLOOK
12.10.4 KEY DEVELOPMENTS
12.11 SILICON BIOSYSTEMS
12.11.1 OVERVIEW
12.11.2 FINANCIAL PERFORMANCE
12.11.3 PRODUCT OUTLOOK
12.11.4 KEY DEVELOPMENTS
12.12 TAKARA BIO INC.
12.12.1 OVERVIEW
12.12.2 FINANCIAL PERFORMANCE
12.12.3 PRODUCT OUTLOOK
12.12.4 KEY DEVELOPMENTS
12.13 VAZYME BIOTECH CO. LTD.
12.13.1 OVERVIEW
12.13.2 FINANCIAL PERFORMANCE
12.13.3 PRODUCT OUTLOOK
12.13.4 KEY DEVELOPMENTS
12.14 YIKANG GENE
12.14.1 OVERVIEW
12.14.2 FINANCIAL PERFORMANCE
12.14.3 PRODUCT OUTLOOK
12.14.4 KEY DEVELOPMENTS